Synopsis
This free monthly podcast is part of Clinical Chemistry. Clinical Chemistry is the leading forum for peer-reviewed, original research on innovative practices in todays clinical laboratory. In addition to being the most cited journal in the field (24,297 citations in 2009), Clin Chem has the highest Impact Factor (6.263 in 2009) among journals of clinical chemistry, clinical (or anatomic) pathology, analytical chemistry, and the subspecialties, such as transfusion medicine, clinical microbiology.
Episodes
-
![Cannabis Effects on Driving Skills]()
Cannabis Effects on Driving Skills
18/03/2013 Duration: 22minCannabis is the most prevalent illicit drug identified in impaired drivers. The effects cannabis has on driving continue to be debated, making legislation and prosecution difficult.
-
![More Data, Please!]()
More Data, Please!
11/03/2013 Duration: 17min"More Data, Please!" That's the provocative title of Dr. Keith Baggerly's editorial in the March 2013 issue of Clinical Chemistry. He was commenting on an article appearing in the previous month of the journal by Kenneth Witwer who joined us in a podcast earlier this year, regarding the state of data reporting in microRNA studies.
-
![MALDI-TOF Mass Spectrometry: Transformative Proteomics for Clinical Microbiology]()
MALDI-TOF Mass Spectrometry: Transformative Proteomics for Clinical Microbiology
04/03/2013 Duration: 04minMass spectrometry has revolutionized many areas of clinical chemistry, but this technology is not just limited to chemistry. Introduction of MALDI-TOF mass spectrometry into the clinical microbiology laboratory has markedly altered workflow allowing bacterial and fungal colonies to be accurately, rapidly, and inexpensively identified.
-
![March 2013 Audio Summary]()
-
![Is Early Detection of Cancer with Circulating Biomarkers Feasible?]()
Is Early Detection of Cancer with Circulating Biomarkers Feasible?
25/02/2013 Duration: 14minEarly cancer detection before metastasis in asymptomatic patients is one of the primary objectives of cancer research initiatives. Early detection generally means more opportunities for intervention that ultimately lead to improvements in patient outcomes.
-
![February 2013 Audio Summary]()
-
![January 2013 Audio Summary]()
-
![MicroRNA Analysis: Is It Ready for Prime Time?]()
-
![Commercial Immunoassays in Biomarkers Studies: Researchers Beware!]()
-
![Data Submission and Quality in Microarray-Based MicroRNA Profiling]()
-
![Comparing Multiple Measures of Glycemia: How to Transition from Biomarker to Diagnostic Test?]()
Comparing Multiple Measures of Glycemia: How to Transition from Biomarker to Diagnostic Test?
04/02/2013 Duration: 18min -
![The Riddle of Protein Diagnostics: Future Bleak or Bright?]()
-
![Conquering Cancer in Our Lifetime: New Diagnostic and Therapuetic Trends]()
-
![Plasma-Derived Tumor DNA Analysis at Whole-Genome Resolution]()
-
![Validating serum markers for monitoring of cancer]()
-
![Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers]()
Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers
03/01/2013 Duration: 11min -
![Associations of Alternative Markers of Glycemia with Hemoglobin A1c and Fasting Glucose]()
Associations of Alternative Markers of Glycemia with Hemoglobin A1c and Fasting Glucose
27/12/2012 Duration: 04min
